April 1st 2025
William Wainwright, business development manager at Iwata Label USA, discusses the practical security benefits of functional labels at INTERPHEX 2025.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
FDA Committees Recommend Ban on Cough and Cold Medications for Young Children
October 24th 2007After a whirlwind of negative press this fall regarding the safety of cough and cold medications for children under age 6, the US Food and Drug Administration?s Nonprescription Drugs and Pediatric Advisory Committees have recommended such over-the-counter drugs no longer be used for young children.
FDA Revises Postmarketing Reporting Requirements for Discontinued Life-Supporting Drugs
October 24th 2007Under a new US Food and Drug Administration revision, sole manufacturers of drugs considered life-supporting, life-sustaining, or for prevention of certain serious diseases or conditions will be required to notify FDA at least six months before discontinuing production of the product.
Drug Makers Voluntarily Recall OTC Infant Cough and Cold Medications
October 18th 2007On behalf of manufacturers of over-the-counter (OTC) infant cough and cold medications, the Consumer Healthcare Products Association announced a voluntary withdrawal of products intended for use in children under age 2.
Sustainable Packaging Resources
October 2nd 2007When it comes to designing and sourcing sustainable packaging, there are no simple answers. Sustainable packaging depends on a complex interaction of environmental, social, and economic considerations, which are influenced by geography and other factors such as renewability, compostability, biodegradability, weight, and performance.
The Application of Quality by Design to Analytical Methods
October 2nd 2007To monitor and control processes or products, analytical methodology must be fit for purpose. An approach to apply quality by design principles to the design and evaluation of analytical methods has therefore been developed to meet these needs. This article features a downloadable template on which to conduct a failure mode effect analysis (FMEA).
Strategy for the Prediction and Selection of Drug Substance Salt Forms
October 2nd 2007Through consideration of the ionic equilibria of acids and bases, one may readily calculate the formation constant of a salt species solely on the basis of knowledge of the pKA value of the acid and the pKB value of the base.